These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30806414)

  • 1. Cancer cell targeting and therapeutic delivery of silver nanoparticles by mesoporous silica nanocarriers: insights into the action mechanisms using quantitative proteomics.
    Montalvo-Quiros S; Aragoneses-Cazorla G; Garcia-Alcalde L; Vallet-Regí M; González B; Luque-Garcia JL
    Nanoscale; 2019 Mar; 11(10):4531-4545. PubMed ID: 30806414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amine-functionalized mesoporous silica nanoparticles decorated by silver nanoparticles for delivery of doxorubicin in breast and cervical cancer cells.
    Ghobadi M; Salehi S; Ardestani MTS; Mousavi-Khattat M; Shakeran Z; Khosravi A; Cordani M; Zarrabi A
    Eur J Pharm Biopharm; 2024 Aug; 201():114349. PubMed ID: 38848782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Transferrin-Conjugated Hollow Nanoplatform for Redox-Controlled and Targeted Chemotherapy of Tumor with Reduced Inflammatory Reactions.
    Zhou J; Li M; Lim WQ; Luo Z; Phua SZF; Huo R; Li L; Li K; Dai L; Liu J; Cai K; Zhao Y
    Theranostics; 2018; 8(2):518-532. PubMed ID: 29290824
    [No Abstract]   [Full Text] [Related]  

  • 4. Negative-charge-functionalized mesoporous silica nanoparticles as drug vehicles targeting hepatocellular carcinoma.
    Xie M; Xu Y; Shen H; Shen S; Ge Y; Xie J
    Int J Pharm; 2014 Oct; 474(1-2):223-31. PubMed ID: 25149125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled synthesis and size effects of multifunctional mesoporous silica nanosystem for precise cancer therapy.
    Ma B; He L; You Y; Mo J; Chen T
    Drug Deliv; 2018 Nov; 25(1):293-306. PubMed ID: 29334793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA-templated in situ growth of silver nanoparticles on mesoporous silica nanospheres for smart intracellular GSH-controlled release.
    Liu C; Qing Z; Zheng J; Deng L; Ma C; Li J; Li Y; Yang S; Yang J; Wang J; Tan W; Yang R
    Chem Commun (Camb); 2015 Apr; 51(30):6544-7. PubMed ID: 25765340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transferrin receptor-targeted HMSN for sorafenib delivery in refractory differentiated thyroid cancer therapy.
    Ke Y; Xiang C
    Int J Nanomedicine; 2018; 13():8339-8354. PubMed ID: 30584304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of silver nanoparticles in the induction of apoptosis on human hepatocellular carcinoma (HepG2) cell line.
    Ahmadian E; Dizaj SM; Rahimpour E; Hasanzadeh A; Eftekhari A; Hosain Zadegan H; Halajzadeh J; Ahmadian H
    Mater Sci Eng C Mater Biol Appl; 2018 Dec; 93():465-471. PubMed ID: 30274079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bactericidal application and cytotoxic activity of biosynthesized silver nanoparticles with an extract of the red seaweed Pterocladiella capillacea on the HepG2 cell line.
    El Kassas HY; Attia AA
    Asian Pac J Cancer Prev; 2014; 15(3):1299-306. PubMed ID: 24606456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo Targeting of Liver Cancer with Tissue- and Nuclei-Specific Mesoporous Silica Nanoparticle-Based Nanocarriers in mice.
    Ding Z; Wang D; Shi W; Yang X; Duan S; Mo F; Hou X; Liu A; Lu X
    Int J Nanomedicine; 2020; 15():8383-8400. PubMed ID: 33149582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology improves the therapeutic efficacy of gemcitabine against a human hepatocellular carcinoma cell line and minimizes its in vivo side effects.
    El-Sheikh SMA; Khairy MH; Osama E; Metwally MMM; Galal AAA
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Apr; 394(4):631-643. PubMed ID: 33104848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lectin-conjugated pH-responsive mesoporous silica nanoparticles for targeted bone cancer treatment.
    Martínez-Carmona M; Lozano D; Colilla M; Vallet-Regí M
    Acta Biomater; 2018 Jan; 65():393-404. PubMed ID: 29127069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined chemo/photothermal therapy based on mesoporous silica-Au core-shell nanoparticles for hepatocellular carcinoma treatment.
    Wang J; Zhang Y; Liu L; Cui Z; Liu X; Wang L; Li Y; Li Q
    Drug Dev Ind Pharm; 2019 Sep; 45(9):1487-1495. PubMed ID: 31172835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etoposide encased folic acid adorned mesoporous silica nanoparticles as potent nanovehicles for enhanced prostate cancer therapy: synthesis, characterization, cellular uptake and biodistribution.
    Saroj S; Rajput SJ
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S1115-S1130. PubMed ID: 30669865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced anti-tumor activity of a drug through pH-triggered release and dual targeting by calcium phosphate-covered mesoporous silica vehicles.
    Liu J; Hu X; Jin S; Liang XJ; Ma X
    J Mater Chem B; 2022 Jan; 10(3):384-395. PubMed ID: 34935843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemcitabine and synthesized silver nanoparticles impact on chemically induced hepatocellular carcinoma in male rats.
    Mohamed MR; Osman SA; Hassan AA; Raafat AI; Refaat MM; Fathy SA
    Int J Immunopathol Pharmacol; 2024; 38():3946320241263352. PubMed ID: 39046434
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
    Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
    J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silver nanoparticles affect glucose metabolism in hepatoma cells through production of reactive oxygen species.
    Lee MJ; Lee SJ; Yun SJ; Jang JY; Kang H; Kim K; Choi IH; Park S
    Int J Nanomedicine; 2016; 11():55-68. PubMed ID: 26730190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesoporous silica nanoparticles decorated with polycationic dendrimers for infection treatment.
    González B; Colilla M; Díez J; Pedraza D; Guembe M; Izquierdo-Barba I; Vallet-Regí M
    Acta Biomater; 2018 Mar; 68():261-271. PubMed ID: 29307796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Evaluation of Transferrin-Modified Porous Silicon Nanoparticles for Targeted Delivery of Doxorubicin to Glioblastoma.
    Luo M; Lewik G; Ratcliffe JC; Choi CHJ; Mäkilä E; Tong WY; Voelcker NH
    ACS Appl Mater Interfaces; 2019 Sep; 11(37):33637-33649. PubMed ID: 31433156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.